Recently, it has been proposed that IL‐6R blockade with TCZ may normalize the activation status of signal transducers and activators of transcription 1 and 3 (STAT1 and STAT3) and may regulate the frequencies of regulatory T cells in relation to reduced inflammation in patients with RA (Ortiz et al., 2015). The gene discussed is STAT1; the disease is rheumatoid arthritis.